Anti-Pappalysin-1 Rabbit Polyclonal Antibody
- Host
- Rabbit, Polyclonal
- Reactivity
- Validated- Human Potential-Mouse, Rat
- UniProt
- Q13219
- Size
- 100ug
- Cat. #
- RP4Pappalysin1
In stock
- SKU
- RP-Pappalysin1
Target Overview
Pappalysin-1 (PAPPA, UniProt Q13219, EC 3.4.24.79) is a secreted metalloproteinase of 1,627 amino acids that specifically cleaves insulin-like growth factor binding proteins IGFBP-4 and IGFBP-5. This proteolytic activity releases bound IGF from the carrier proteins, increasing local IGF bioavailability. Cleavage of IGFBP-4 is dramatically enhanced by the presence of IGF, whereas cleavage of IGFBP-5 is slightly inhibited by IGF. Originally identified as pregnancy-associated plasma protein A (PAPP-A) due to its abundance in maternal serum during gestation, Pappalysin-1 plays critical roles in placental development, bone remodeling, and wound healing. The enzyme is synthesized as a proprotein and undergoes autocatalytic processing to generate the mature, active metalloproteinase. Researchers studying IGF signaling, placental physiology, skeletal biology, and cardiovascular pathology rely on Pappalysin-1 detection to monitor protease expression, localization, and disease-associated changes in IGFBP processing.
Background
References
- Cristofor AE et al (2026) Comparison of Machine Learning Models and the FMF Competing-Risks Algorithm for First-Trimester Preeclampsia Screening in a Romanian Cohort. Diagnostics (Basel). PubMed · DOI
- Hua R et al (2026) First trimester, one-tube screening for pregnancy complications via placental biomarkers. BMC Pregnancy Childbirth. PubMed · DOI
- Lytsen RM et al (2026) Association of HDL cholesterol, apolipoprotein AI, and E concentrations with foetal growth and placental insufficiency. Cardiovasc Res. PubMed · DOI
- Torun R et al (2026) Correlation Between Placental Hormones and Placental Elasticity and the Relationship Between These Parameters and Pregnancy Outcomes. J Clin Ultrasound. PubMed · DOI
- Al Naimi A et al (2026) The utility of serum markers in the conservative management of placenta accreta spectrum (PAS) by leaving the placenta in situ in women with high-grade PAS. Int J Gynaecol Obstet. PubMed · DOI
Additional Specifications
| Gene Symbol | PAPPA |
|---|---|
| UniProt ID | Q13219 |
| Host Species | Rabbit |
| Species Reactivity | Validated- Human Potential-Mouse, Rat |
| Pack Size | 100ug |
| Immunogen (Propeptide domain) | Immunogen is proprietary and confidential. Immunogen generated in amino acid region 23-81. |
| Immunogen (Carboxy end Propeptide Domain) | Immunogen is proprietary and confidential. Immunogen generated in amino acid region 61-81. |
| Immunogen (LamGL Domain) | Immunogen is proprietary and confidential. Immunogen generated in amino acid region 700-900. |
| Immunogen (Catalytic domain) | Immunogen is proprietary and confidential. Immunogen generated in amino acid region 82-1627. |
| Immunogen (Carboxyterminal end) | Immunogen is proprietary and confidential. Immunogen generated in amino acid region 1577-1627. |
| Alternate Names | PAPPA, Pappalysin-1, Pregnancy-associated plasma protein A, PAPP-A, EC 3.4.24.79, Insulin-like growth factor-dependent IGF-binding protein 4 protease, IGF-dependent IGFBP-4 protease, IGFBP-4ase |
Frequently Asked Questions
What molecular weight should I expect for Pappalysin-1 on a Western blot?
Full-length Pappalysin-1 runs at approximately 200 kDa on reducing SDS-PAGE, reflecting the 1,627-amino-acid proprotein. You may also detect the mature processed form around 160–180 kDa depending on the extent of autocatalytic cleavage. Because Pappalysin-1 is heavily glycosylated, the apparent molecular weight often exceeds the calculated mass. If you are working with conditioned media or serum samples, you may see additional bands corresponding to complexes with proMBP (pro-major basic protein) or fragments. Start with 1:1000 dilution and verify band identity with a positive control lysate enriched in PAPPA expression.
Does this antibody distinguish between the proenzyme and mature active Pappalysin-1?
The epitope specificity depends on the immunogen region used by Triple Point Biologics. Most polyclonal Pappalysin-1 antibodies recognize both the proenzyme and the mature processed form because the catalytic domain is retained after autocatalytic cleavage. If your experimental design requires discrimination between zymogen and active enzyme, confirm epitope mapping with the manufacturer or consider functional assays such as IGFBP-4 cleavage in parallel. Western blotting will typically show both forms; the relative intensity can indicate processing state in your sample. Context-dependent autocatalytic maturation is particularly relevant in pregnancy serum, atherosclerotic plaques, and wound-healing models.
Will this rabbit anti-human Pappalysin-1 antibody cross-react with mouse or rat samples?
Cross-reactivity with mouse and rat is predicted but not yet validated by Triple Point Biologics for this clone. Human, mouse, and rat Pappalysin-1 share approximately 85–90 percent sequence identity in conserved metalloproteinase domains, so cross-reactivity is plausible. If you are working with rodent samples, perform a pilot Western blot alongside a human positive control to confirm signal specificity. Check for a band near 200 kDa and verify it disappears with peptide competition or in knockout tissue if available. Report your findings; user-generated validation data help refine species reactivity claims for the research community.
What sample types work best for detecting Pappalysin-1 with this antibody?
Pappalysin-1 is a secreted metalloproteinase, so conditioned culture media, serum, plasma, and tissue lysates from placenta, bone, or vascular smooth muscle are suitable sources. For cell lysates, use a lysis buffer containing protease inhibitors that spare metalloproteases if you want to preserve potential activity, or include EDTA to capture total enzyme. Serum from pregnant women is a classical positive control due to high PAPP-A levels. For tissue, homogenize in non-denaturing buffer first, then add SDS sample buffer for Western blot. Avoid freeze-thaw cycles; aliquot samples to maintain protein integrity and reduce aggregation of this large glycoprotein.
What starting dilution should I use for Western blot and can I use this antibody for IHC?
For Western blot, start at 1:1000 dilution in blocking buffer (5 percent non-fat milk or BSA in TBST). This antibody is a rabbit polyclonal, so you may optimize between 1:500 and 1:2000 depending on expression level and your detection system. Triple Point Biologics antibodies are routinely validated for immunohistochemistry; try 1:100 to 1:400 for paraffin-embedded sections. Antigen retrieval with citrate buffer (pH 6.0) or Tris-EDTA (pH 9.0) is usually necessary for PAPPA. Include a negative control (non-immune rabbit IgG) and a known positive tissue (first-trimester placenta or atherosclerotic plaque) to confirm staining specificity.
How should I store this Pappalysin-1 antibody and what is its shelf life?
Store the antibody at –20°C in small aliquots to avoid repeated freeze-thaw cycles, which can reduce titer and increase aggregation. The 100-µg pack size allows you to make ten 10-µg working aliquots in glycerol-supplemented storage buffer (50 percent glycerol prevents complete freezing and permits storage at –20°C). Under these conditions, polyclonal antibodies typically retain activity for two to three years. Once thawed, an aliquot can be kept at 4°C for up to one month; add 0.02 percent sodium azide if you plan extended refrigerated storage. Always centrifuge briefly before use to pellet any precipitate. Check the product datasheet for lot-specific expiration dates.
What are good positive and negative controls for validating Pappalysin-1 detection?
For a positive control, use lysate or conditioned medium from a cell line overexpressing PAPPA (e.g., transfected HEK293 or JAR choriocarcinoma cells), first-trimester placental tissue lysate, or serum from a pregnant woman in the second or third trimester when PAPP-A levels peak. Recombinant Pappalysin-1 protein is also commercially available. For a negative control, test lysate from a PAPPA-knockout cell line or tissue known to express little enzyme, such as resting T lymphocytes or liver. Peptide competition with the immunizing peptide (if disclosed by the manufacturer) provides additional specificity confirmation. These controls help distinguish true signal from non-specific bands in your system.
Does Pappalysin-1 form complexes that affect antibody detection on Western blots?
Yes. Pappalysin-1 circulates predominantly as a 2:2 heterotetrameric complex with the proform of eosinophil major basic protein (proMBP, also called PAPPA2). Under non-reducing conditions or in native gels, you may detect very high molecular weight species (400 kDa or greater). Reducing SDS-PAGE disrupts these complexes and releases monomeric PAPPA at approximately 200 kDa. If you are analyzing serum or conditioned media, be aware that a fraction of enzyme also exists as disulfide-linked homodimers. Running samples under reducing conditions (with DTT or β-mercaptoethanol) simplifies the banding pattern and is recommended for initial characterization.
Western blot validation for RP-Pappalysin1 — 5 panels across the domain-specific antibody variants. Each blot below shows the clone that validates a specific domain of the target protein.
Custom validation studies available on request — contact us.
Also known as:
- PAPPA
- Pappalysin-1
- Pregnancy-associated plasma protein A
- PAPP-A
- EC 3.4.24.79
- Insulin-like growth factor-dependent IGF-binding protein 4 protease
- IGF-dependent IGFBP-4 protease
- IGFBP-4ase